Up­dat­ed: Lil­ly de­tails mid-stage win for tirzepatide in MASH with fi­bro­sis da­ta

Eli Lil­ly has un­veiled fi­bro­sis re­sults from a Phase 2 test of tirzepatide in pa­tients with meta­bol­ic dys­func­tion-as­so­ci­at­ed steato­hep­ati­tis, or MASH, which could help fur­ther …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER